1Suzaki Y, Yosizumi M, Yamashita y. et al. Determination of plasma concentrations of endothelin- 1(1 - 31 ) and endothelin-1 in healthy subjects and patients with Atherosclerosis[J]. J Cardiovuasc Pharmacol, 2003,41 (suppl l ) : s83.
2Maguire J, Kuc RE, Davenport Ap, et al. Vasoconstric-tor activity of novel endothelin peptide, ET- 1 (1-31) in human mammary and coronary arteries invitro[J]. Br J pharmacol.2001,134(6) : 1360.
3Mawatar K, Skakui, Harada N, et al Endothelin-1(1-31)level are increased in atherosclerotic lesions of the thoracic aorta of hypercholesterolemi chamsters [J], Atherosclerosis. 9004,175(2) : 203.
4Kathryn J, Macleod, Rhonda D, et al. Constitutive phosphorylation of Human Endothelin- converting enzyme- 1 Isoforms[J].J Biochem,2002,277 : 46355.
5Muller L, Barret A, Etienne E, et al. Heterodimerization of Endothelin - converting enzyme- 1 Isoforms Regulates the Subcellular Distribtion of this metalloptotease [J].J Biochem,2003,278(1) : 545.
6Ikeda S, Emoto N, Alimsardiono H. et al. Molecular isolation and characterization of novel four subisoforms of ECE-2[J].Biochem Biophys Res Commun. 2002,293(1 ): 421.
7Davenport A, Kul R. Cellular expression of isoforms of endothelin - converting enzyme - 1 and endothelin - converting nzyme - 2 [J]. J Cardiovas Pharmacol , 2000,36 ( 5suppl 1 ) :s12.
8Jasmin JF, Dupuis J. Evaluation of luminal enothelin-converting enzyme activity in the pulmonary and coronary circulations[J].J cardiovasc Pharmacol, 2004,43 ( 1 ) : 21.
9Jasmin JF, Dupuis J. Evaluation of luminal endothelin - con verting enzyme activity in the pulmonary and coronary circulations[J]. J cardiovasc Pharmacol ,2004,43(1) : 21.
7YANG D, LI J H, GAO Q, et al. Lanthanide triflate-promoted palladium-catalyzed cyclization of alkenyl a-jeto esters and amides[J] .Organic Letters,200$, 5(16) :2869 - 2871.
8TIRPAK R E, RATHKE M W. Acylation of ketone silyl enol ethers with acid chlorides.Synthesis of 1,3-diketones[J] .J Org Chem,1982,47:5099- 5102.
